Mixed Topics
Conference Coverage
No Increase in Autoimmune Risk Seen With GLP-1 Receptor Agonists and SGLT2 Inhibitors
Patients with type 2 diabetes prescribed GLP-1 receptor agonists or SGLT2 inhibitors did not have a greater risk of developing autoimmune disease...
Latest News
Patient-Reported Outcomes Predict Mortality in Cutaneous Chronic GVHD
Study findings are relevant to dermatologists in academic and transplant centers and the community who provide skin cancer screenings or other...
Latest News
Bigfoot, Bermuda Triangle, ‘No Lido With Epi’?
Myth of gangrenous potential when using combination of epinephrine and lidocaine in procedures in areas of low blood flow is addressed.
Latest News
Oral Herpes Tied to Double Dementia Risk in Older Adults
Past infection with HSV in older adults was linked to higher risk for developing dementia, study finds.
News from the FDA/CDC
FDA Removes Harmful Chemicals From Food Packaging
The “major source of dietary exposure to PFAS from food packaging” is being eliminated.
Latest News
Will 2024 Be Easier on the Eyes?
Combo treatments or new drug delivery methods may offer patients an alternative or prolonged intervals between injections.
Latest News
Is Metformin a ‘Drug for All Diseases’?
Long time diabetes medication, metformin may have utility in treatment of obesity, liver disease, cancers, and other diseases.
Latest News
The Ghost Research Haunting Nordic Medical Trials
Numerous studies could be considered ‘medical research waste’ or research that was never shared publicly, study finds.
Latest News
Use of Biologics for Psoriasis Found to Confer a Survival Benefit
The study population consisted of 18,618 psoriasis cases and 55,854 controls.
Feature
Balancing Patient Satisfaction With Saying No
How to deal with patient requests and still address some of their concerns.
Latest News
New Antibiotic Promising for Complicated UTIs
Study suggests cefepime-taniborbactam could be useful in treating complex UTIs.